VKB-20900-72444
4 vaccinations
10 coded responses
18 check-ins
10 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 921 / CA
- Registered
- 2021-03-22
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-28
Dose 1 — Pfizer-BioNTech
-
2021-03-21
Dose 2 — Pfizer-BioNTech
-
2021-03-22
Registered in v-safe
-
2021-03-22
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-03-23
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Redness, Swelling · Headache, Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-03-25
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Itching · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-30
-
2021-04-05
Survey response — day 14, dose 2MedDRA: Inflammation, Rash — Feeling: FairFree text: Rashes, local inflammationMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-22
- 2021-09-21
-
2021-10-15
Dose 3 — Pfizer-BioNTechCo-administered: Flu
-
2022-03-21
Survey response — 12 months, dose 2MedDRA: Abortion spontaneous — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: Was pregnant since 11/13/2021 then miscarried (b)(6).MedDRA releases: 2024-11 · check-in free text available
-
2022-03-21
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2022-03-23
-
2022-04-16
Dose 4 — Moderna
-
2022-04-20
Survey response — days 1–6 daily, dose 4MedDRA: Dizziness — Feeling: Fair · Site: Itching · Headache, Fatigue or tiredness, Rash, not including the immediate area around the injection siteFree text: DizzinessMedDRA releases: 2024-11 · check-in free text available
-
2022-04-21
Survey response — days 1–6 daily, dose 4MedDRA: Dizziness, Vertigo — Feeling: Fair · Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Dizziness/vertigoMedDRA releases: 2024-11 · check-in free text available
-
2022-04-22
Survey response — days 1–6 daily, dose 4MedDRA: Dizziness, Vertigo — Feeling: Fair · Nausea · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Dizziness/vertigoMedDRA releases: 2024-11 · check-in free text available
-
2022-04-22
Report sent to call center — days 1–6 daily, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-04-23
Survey response — day 7, dose 4MedDRA: Dizziness — Feeling: Good · Fatigue or tirednessFree text: DizzinessMedDRA releases: 2024-11 · check-in free text available
-
2022-04-26
Call successfulReported to VAERS voluntarily prior to GDIT contact
- 2022-04-30
-
2022-05-07
Survey response — day 21, dose 4MedDRA: Vertigo — Feeling: Fair · Be unable to do your normal daily activitiesFree text: VertigoMedDRA releases: 2024-11 · check-in free text available
-
2022-05-14
Survey response — day 28, dose 4MedDRA: Abortion spontaneous — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Miscarriage complicationspersistent/worsening bleeding.MedDRA releases: 2024-11 · check-in free text available
-
2022-05-14
Report sent to call center — day 28, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-05-16
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-05-21
-
2022-05-28
Survey response — day 42, dose 4MedDRA: Abortion spontaneous, Hysteroscopy abnormal, Retained products of conception, Surgery — Feeling: Fair · Be unable to do your normal daily activitiesFree text: RPOC following miscarriage (not related to vaccinations). Had hysteroscopy surgery this week to remove RPOC.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-15
Survey response — 6 months, dose 4MedDRA: Biochemical pregnancy — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Chemical pregnancyMedDRA releases: 2024-11 · check-in free text available
-
2022-10-15
Report sent to call center — 6 months, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-10-17
Call successfulReported to VAERS voluntarily prior to GDIT contact
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-28 | Pfizer-BioNTech | |
| 2 | 2021-03-21 | Pfizer-BioNTech | |
| 3 | 2021-10-15 | Pfizer-BioNTech | Flu |
| 4 | 2022-04-16 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-03-21 | Successful | Not applicable - Accidental Reporting |
| 2022-04-22 | Successful 2022-04-26 |
Reported to VAERS voluntarily prior to GDIT contact |
| 2022-05-14 | Successful 2022-05-16 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
| 2022-10-15 | Successful 2022-10-17 |
Reported to VAERS voluntarily prior to GDIT contact |
Free text
Release 6 — day 14, dose 2
Symptoms: Rashes, local inflammation
Release 11 — 12 months, dose 2
Release 11 — days 1–6 daily, dose 4
Systemic reaction (other): Dizziness
Systemic reaction (other): Dizziness/vertigo
Systemic reaction (other): Dizziness/vertigo
Release 11 — day 7, dose 4
Systemic reaction (other): Dizziness
Release 11 — day 21, dose 4
Symptoms: Vertigo
Release 11 — day 28, dose 4
Symptoms: Miscarriage complicationspersistent/worsening bleeding.
Release 11 — day 42, dose 4
Symptoms: RPOC following miscarriage (not related to vaccinations). Had hysteroscopy surgery this week to remove RPOC.
Release 12 — 6 months, dose 4
Symptoms: Chemical pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | · | · | ✓ |
| SD | Biochemical pregnancy | · | · | ✓ |
| SD | Hysteroscopy abnormal | · | · | ✓ |
| SD | Inflammation | ✓ | ✓ | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SD | Retained products of conception | · | · | ✓ |
| SD | Surgery | · | · | ✓ |
| SD | Vertigo | · | · | ✓ |
| SRO | Dizziness | · | · | ✓ |
| SRO | Vertigo | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release